High-yield overview
'Spotted Bone Disease' | Benign Sclerosing Dysplasia | Multiple Enostoses | LEMD3 Mutation
1:50Kestimated prevalence
LEMD3germline mutation
ADautosomal dominant
Benignno treatment needed
WHAT YOU MUST RECOGNISE
Isolated osteopoikilosis
PatternSpotted bones alone, asymptomatic
TreatmentReassurance, no treatment
Buschke-Ollendorff syndrome
PatternOsteopoikilosis plus skin connective-tissue naevi
TreatmentReassurance, dermatology input
Mistaken for metastases
PatternSpots misread as blastic deposits
TreatmentAvoid unnecessary work-up; bone scan is normal
Critical Must-Knows
- Spotted bone disease - numerous small, round, well-defined sclerotic foci (enostoses) clustered around joints (epiphyses and metaphyses), usually symmetrical and bilateral
- Benign and almost always asymptomatic - an incidental radiographic finding requiring no treatment
- Do-not-touch lesion - the most important job is to recognise it and avoid mistaking the spots for sclerotic (blastic) bone metastases
- Bone scan is normal - no increased radiotracer uptake, which separates it from metastases and active disease
- LEMD3 (MAN1) germline mutation - autosomal dominant; when combined with skin connective-tissue naevi it is called Buschke-Ollendorff syndrome
Clinical Pearls
- "Describe the spotted-bone pattern: multiple small round sclerotic foci concentrated in epiphyses and metaphyses, sparing the skull, ribs, vertebral bodies and mandible
- "State the single most important point: it is a do-not-touch, benign condition often confused with osteoblastic metastases - a normal bone scan resolves the dilemma
- "Know the family of sclerosing dysplasias: osteopoikilosis (round spots), osteopathia striata (linear striations), melorheostosis (dripping candle wax) - all linked to LEMD3
- "Name the named association: osteopoikilosis plus skin elastic-tissue naevi equals Buschke-Ollendorff syndrome
Critical Osteopoikilosis Exam Points
It Is a Do-Not-Touch Lesion
Benign, asymptomatic, incidental. No biopsy, no excision, no treatment. The clinical task is recognition and reassurance. The danger is over-investigation, not the disease itself.
The Killer Differential: Blastic Metastases
Sclerotic (osteoblastic) metastases are the dangerous mimic. Osteopoikilosis spots are uniform, small, round, symmetrical and periarticular; metastases are irregular, variable in size, often axial (spine, ribs, pelvis) and clinically symptomatic.
Normal Bone Scan Clinches It
No increased uptake on Tc-99m bone scan. Enostoses are metabolically inactive mature bone. Increased uptake should make you doubt the diagnosis and exclude metastases or another active lesion.
Buschke-Ollendorff Syndrome
Osteopoikilosis plus skin connective-tissue naevi (dermatofibrosis lenticularis disseminata). Same LEMD3 gene. Look at the skin and ask about family history - it is autosomal dominant.
Quick Decision Guide
| Clinical Scenario | Key Features | Action | Exam Pearl |
|---|---|---|---|
| Incidental spots on radiograph, asymptomatic | Small round symmetrical periarticular sclerotic foci | Reassure, no treatment, document as benign | Most cases are discovered incidentally on imaging done for another reason |
| Spots plus known cancer history | Cannot confidently exclude blastic metastases | Tc-99m bone scan; if no uptake, osteopoikilosis confirmed | A normal bone scan is the cheapest way to settle the diagnosis |
| Atypical: pain, large or enlarging spot, abnormal uptake | Features outside the benign pattern | Treat as a suspicious lesion; cross-sectional imaging and consider biopsy | Atypical enostoses can mimic low-grade osteosarcoma or osteoid osteoma |
Mnemonic
SPOTSDiagnostic Features of Osteopoikilosis
| S | Small round sclerotic foci Multiple uniform enostoses, a few mm in size |
| P | Periarticular and symmetrical Cluster in epiphyses and metaphyses near joints, usually bilateral |
| O | Osteoblastic metastasis is the mimic The key dangerous differential to exclude |
| T | Tc-99m bone scan is normal No increased uptake - distinguishes from metastases |
| S | Spares axial flat bones Skull, ribs, vertebral bodies and mandible typically spared |
| S | Small round sclerotic foci Multiple uniform enostoses, a few mm in size | T | Tc-99m bone scan is normal No increased uptake - distinguishes from metastases |
| P | Periarticular and symmetrical Cluster in epiphyses and metaphyses near joints, usually bilateral | S | Spares axial flat bones Skull, ribs, vertebral bodies and mandible typically spared |
| O | Osteoblastic metastasis is the mimic The key dangerous differential to exclude |
Hook:SPOTS - think of the spotted appearance of the bones! It is the spotted-bone disease that must not be mistaken for cancer.
Mnemonic
SOMLEMD3 Sclerosing Dysplasia Family
| S | Spotted bones (osteopoikilosis) Round sclerotic foci, LEMD3 germline mutation |
| O | Osteopathia striata Linear vertical striations, especially long-bone metaphyses |
| M | Melorheostosis Dripping candle wax cortical hyperostosis (mainly somatic MAP2K1) |
| S | Spotted bones (osteopoikilosis) Round sclerotic foci, LEMD3 germline mutation |
| O | Osteopathia striata Linear vertical striations, especially long-bone metaphyses |
| M | Melorheostosis Dripping candle wax cortical hyperostosis (mainly somatic MAP2K1) |
Hook:SOM - the three sclerosing dysplasias on the LEMD3/MAN1 pathway that overlap as mixed sclerosing bone dysplasia. They can coexist in the same patient or family.
Mnemonic
ROUNDDifferentiating from Blastic Metastases
| R | Round and regular Spots are uniform and well-defined, unlike irregular metastases |
| O | Only periarticular Cluster near joints; metastases favour axial skeleton |
| U | Uptake absent on bone scan Metabolically inactive; metastases are hot |
| N | No symptoms Asymptomatic; metastases usually cause pain |
| D | Don't change over time Radiographically stable for years; metastases evolve |
| R | Round and regular Spots are uniform and well-defined, unlike irregular metastases | N | No symptoms Asymptomatic; metastases usually cause pain |
| O | Only periarticular Cluster near joints; metastases favour axial skeleton | D | Don't change over time Radiographically stable for years; metastases evolve |
| U | Uptake absent on bone scan Metabolically inactive; metastases are hot |
Hook:ROUND - the spots are ROUND and the diagnosis is benign. Each letter is a feature that argues against metastases.
Overview and Epidemiology
Clinical Significance
Osteopoikilosis (from Greek: osteon = bone, poikilos = spotted or mottled) is a benign, usually asymptomatic sclerosing bone dysplasia characterised by multiple small, round, well-defined sclerotic foci (enostoses or bone islands) scattered through the skeleton with a striking periarticular concentration. It is almost always discovered incidentally. Its examination importance is disproportionate to its rarity: it is a classic do-not-touch lesion and a notorious mimic of sclerotic bone metastases. When it occurs together with skin connective-tissue naevi it forms Buschke-Ollendorff syndrome.
Demographics
- Prevalence: estimated around 1 in 50,000 (Buschke-Ollendorff syndrome quoted near 1 in 20,000)
- Age: any age; often detected in adolescence or adulthood
- Gender: roughly equal male:female distribution
- Inheritance: autosomal dominant (germline LEMD3 mutation); sporadic cases occur
- Distribution: usually bilateral and symmetrical
Natural History
- Onset: present from childhood; lesions may increase in number with age
- Course: benign, stable, no malignant transformation of the spots themselves
- Symptoms: usually none; a minority report mild joint pain or effusion
- Prognosis: excellent - it does not affect life expectancy
- Key risk: the risk is iatrogenic over-investigation, not the disease
Anatomic Distribution
The spotted foci show a highly characteristic distribution that itself supports the diagnosis:
- Periarticular predominance: clustered in the epiphyses and metaphyses around joints
- Appendicular skeleton: hands, feet, pelvis, and the ends of long bones are most heavily involved
- Symmetry: typically bilateral and roughly symmetrical
- Classically spared: skull, ribs, clavicles, vertebral bodies and mandible are usually spared
This periarticular, symmetrical, small-tubular-bone pattern is the opposite of the axial-predominant, irregular pattern of sclerotic metastases, and recognising it is the heart of the exam answer.
Pathophysiology and Genetics
LEMD3 Germline Mutation
Molecular Pathogenesis
According to PubMed, Hellemans and colleagues (2004) showed that heterozygous loss-of-function germline mutations in LEMD3 (which encodes the inner nuclear membrane protein MAN1) cause osteopoikilosis, Buschke-Ollendorff syndrome and some cases of melorheostosis. MAN1 normally antagonises TGF-beta / BMP signalling through interaction with receptor-activated SMADs. Loss of this brake leads to excess bone-forming signalling and the focal sclerotic noduli that define the disease.
Molecular Mechanism
- Gene: LEMD3 (also called MAN1), on chromosome 12
- Protein: MAN1, an inner nuclear membrane protein
- Mutation type: heterozygous loss-of-function (germline)
- Pathway: antagonist of TGF-beta and BMP / SMAD signalling
- Effect: loss of the brake on bone-forming signalling
Spectrum and Overlap
- Osteopoikilosis: round sclerotic foci (LEMD3 germline)
- Buschke-Ollendorff: osteopoikilosis plus skin naevi (same gene)
- Osteopathia striata: linear striations, overlapping spectrum
- Melorheostosis: mainly somatic MAP2K1, but can coexist
- Mixed sclerosing bone dysplasia: features of more than one
Histopathology
Microscopic examination of an osteopoikilotic focus shows the features of a benign enostosis (bone island):
- Mature compact lamellar bone: dense, well-organised lamellar bone within cancellous bone
- Haversian systems: normal osteons may be present within the focus
- Blends with trabeculae: spicules of the island merge with surrounding trabecular bone (the radiographic rose-thorn or brush border)
- Modeling-based bone formation: studies of Buschke-Ollendorff syndrome describe sclerotic noduli arising from modeling-based bone formation with a largely normal remodeling rate
- No woven bone, no atypia, no inflammation: distinguishes it from malignancy, infection and active reactive bone
Sclerosing Dysplasia Family
A Family of Related Conditions
Osteopoikilosis sits within a group of related sclerosing dysplasias that share the LEMD3 pathway and can overlap in a single patient:
- Osteopoikilosis - multiple round sclerotic foci (spotted bones)
- Osteopathia striata - linear vertical striations, classically in long-bone metaphyses and the ilium
- Melorheostosis - dripping candle wax cortical hyperostosis (predominantly somatic MAP2K1)
- Mixed sclerosing bone dysplasia - a combination of these patterns in one skeleton
Clinical Presentation
Cardinal Features
How It Presents
Osteopoikilosis is usually silent. The typical presentation is an unexpected radiographic finding:
- Incidental discovery (most): spots seen on imaging done for trauma or another reason
- Asymptomatic (most): no pain, no functional limitation
- Mild joint symptoms (minority): aching or effusion, often coincidental
- Skin lesions (Buschke-Ollendorff): yellowish papules or plaques (connective-tissue naevi)
- Family screening: spotted bones found when relatives of an affected patient are imaged
Musculoskeletal Findings
- Pain: usually absent; if present, consider another cause
- Examination: typically normal joint and limb examination
- Function: unaffected
- Deformity: none (unlike melorheostosis)
- Stability: radiographically stable over years
Skin (Buschke-Ollendorff)
- Connective-tissue naevi: yellowish papules or plaques
- Dermatofibrosis lenticularis disseminata: the classic term
- Distribution: trunk, buttocks, limbs
- Symptoms: usually asymptomatic, not itchy or painful
- Histology: excess broad elastic and/or collagen fibres
Why It Matters Clinically
The clinical importance of osteopoikilosis is almost entirely diagnostic:
- Avoiding harm: recognising the benign pattern prevents unnecessary biopsy, cross-sectional imaging and oncological referral
- Reassurance: patients (and other clinicians) need clear reassurance that the spots are not cancer
- Cancer co-existence: a patient with osteopoikilosis can still develop a malignancy, so persistent or atypical symptoms still deserve assessment - the spots simply should not be assumed to be metastases
- Genetic counselling: in Buschke-Ollendorff syndrome the autosomal-dominant inheritance is relevant to the family
Imaging and Diagnosis
Radiographic Imaging - Diagnostic Standard
The Spotted-Bone Pattern
The diagnosis is usually made confidently on plain radiographs. The hallmark is multiple small (typically 1 to 10 mm), round to ovoid, well-defined sclerotic foci concentrated in the epiphyses and metaphyses around joints, distributed bilaterally and symmetrically. Individual foci are enostoses (bone islands) and may show a fine spiculated rose-thorn / brush border blending with the surrounding trabeculae.
Key Radiographic Features:
- Multiple small round sclerotic foci: uniform, well-defined
- Periarticular clustering: epiphyses and metaphyses near joints
- Bilateral and symmetrical: a strong clue to the benign nature
- Sites: hands, feet, pelvis, proximal femur, around the shoulder, knee and ankle
- Spares: skull, ribs, vertebral bodies and mandible
- Stable over time: unchanged on serial films, unlike metastases
Imaging Gallery
Cross-Sectional and Nuclear Imaging
CT
- Appearance: dense sclerotic foci with very high attenuation
- Attenuation: enostoses typically have mean CT values well above 885 Hounsfield units
- Role: helpful for an atypical or solitary lesion when bone island versus metastasis is in doubt
Bone Scan (Tc-99m)
- Appearance: no increased uptake at the foci
- Reason: enostoses are metabolically inactive mature bone
- Role: the key test - a normal scan effectively excludes active metastases and confirms benignity
When NOT to Be Reassured
Most osteopoikilosis is benign and needs nothing further. Be cautious - and treat the lesion as suspicious - if any of these atypical features are present, because atypical enostoses can mimic blastic metastasis, low-grade central osteosarcoma or osteoid osteoma:
- Local pain or tenderness over a focus
- Increased uptake on bone scan
- Enlargement of a focus on serial imaging
- Unusually large size or aggressive-looking margins
- Atypically low CT attenuation for a bone island
Management
Principles
The Whole Treatment Is Recognition
For typical osteopoikilosis there is no medical or surgical treatment and none is needed. The entire management plan is: confirm the benign diagnosis radiographically, use a bone scan to exclude metastases if there is any doubt, reassure the patient, document it clearly so it is not re-investigated, and avoid biopsy or excision. It is the textbook do-not-touch lesion.
For the classic, asymptomatic, incidental presentation:
- Confirm pattern: small round symmetrical periarticular sclerotic foci on plain films
- No biopsy, no treatment: managed by recognition alone
- Reassure: explain it is a benign, harmless, often inherited spotted-bone variant
- Document: record the diagnosis prominently to prevent future unnecessary work-up
- Skin check: look for connective-tissue naevi (Buschke-Ollendorff) and consider family history
Genetic and Family Considerations
- Inheritance: autosomal dominant; first-degree relatives may carry the same LEMD3 variant
- Counselling: in Buschke-Ollendorff syndrome, explain the inheritance and the benign nature of both the bone and skin findings
- Dermatology: connective-tissue naevi are cosmetic only and rarely need intervention
Complications and Pitfalls
The Real Complications Are Diagnostic
The disease itself is benign; the complications in practice come from mismanagement and from coincidental disease:
- Misdiagnosis as metastases: leading to unnecessary anxiety, imaging, biopsy and even oncological referral - the single most important pitfall
- Unnecessary biopsy: of a do-not-touch lesion
- Missing a real lesion: anchoring on osteopoikilosis and dismissing a genuinely symptomatic or atypical focus that is actually a tumour
- Overlooking Buschke-Ollendorff syndrome: failing to examine the skin or take a family history
- Rare reported associations: occasional reports of dystocia, joint effusions and other findings, but these are not consistent features
Do
- Recognise the symmetrical periarticular spotted pattern
- Use a bone scan to settle doubt against metastases
- Reassure and document clearly
- Examine the skin for connective-tissue naevi
- Re-evaluate any genuinely atypical focus on its own merits
Avoid
- Biopsying a classic, asymptomatic spotted-bone pattern
- Labelling spots as metastases without a bone scan
- Anchoring: dismissing a real symptomatic lesion as osteopoikilosis
- Treating a benign condition that needs no treatment
- Forgetting the autosomal-dominant inheritance in counselling
Clinical Relevance and Exam Focus
Why Examiners Love This Topic
Osteopoikilosis is a favourite because it tests pattern recognition and clinical judgement rather than complex management. The examiner wants to see that you can (1) recognise a benign do-not-touch lesion, (2) construct a sensible differential for sclerotic bone lesions, (3) use the right single test (bone scan) to exclude the dangerous mimic, and (4) avoid harming the patient with unnecessary investigation. A confident, calm answer that prioritises not biopsying a benign lesion scores well.
Differential Diagnosis of Multiple Sclerotic Bone Lesions
Multiple Sclerotic Foci - Differential
| Condition | Pattern | Bone Scan | Discriminator |
|---|---|---|---|
| Osteopoikilosis | Small round symmetrical periarticular foci | Normal (cold) | Benign, asymptomatic, stable; spares axial flat bones |
| Osteoblastic metastases | Irregular variable foci, axial predominance | Increased uptake (hot) | Symptomatic, known primary, evolves over time |
| Tuberous sclerosis / mastocytosis | Sclerotic foci, may be axial | Variable | Systemic features and other organ involvement |
| Osteopathia striata | Linear vertical striations in metaphyses | Normal | Striped not spotted; same LEMD3 family |
Key Associations to Remember
- Buschke-Ollendorff syndrome: osteopoikilosis plus skin connective-tissue naevi (same LEMD3 gene)
- Gardner syndrome: multiple osteomas and bone islands with colonic polyposis - a separate condition, but a reminder that multiple bone islands occasionally signal a syndrome, so consider the whole patient
- Mixed sclerosing bone dysplasia: overlap with osteopathia striata and melorheostosis in the same skeleton
Evidence and Key Studies
Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis
Hellemans J, Preobrazhenska O, Willaert A, et al. • Nature Genetics (2004)
Key Findings:
- Heterozygous loss-of-function germline mutations in LEMD3 (MAN1) cause osteopoikilosis and Buschke-Ollendorff syndrome
- Established the autosomal-dominant genetic basis of the spotted-bone phenotype on chromosome 12
- MAN1 antagonises BMP and TGF-beta signalling by interacting with receptor-activated SMADs - losing this brake favours bone formation
- Some patients with melorheostosis also carried LEMD3 mutations, linking the three sclerosing dysplasias on one pathway
Clinical Implication: Explains why osteopoikilosis, Buschke-Ollendorff syndrome and some melorheostosis cluster in families and overlap; supports examining the skin and taking a family history because the condition is autosomal dominant.
Melorheostosis and osteopoikilosis: a review of clinical features and pathogenesis
Wordsworth P, Chan M • Calcified Tissue International (2019)
Key Findings:
- Osteopoikilosis is caused by germline LEMD3 mutations that perturb TGF-beta / BMP signalling via the nuclear-membrane protein MAN1
- It can co-occur with melorheostosis, supporting a shared signalling pathway across the sclerosing dysplasias
- There is substantial radiographic overlap within mixed sclerosing bone dysplasia
- Distinguishing benign sclerosing dysplasia from malignancy remains the central clinical challenge
Clinical Implication: Frames osteopoikilosis within a family of LEMD3-related sclerosing dysplasias and reinforces that the practical task is separating benign sclerosis from malignancy rather than treating the bone.
Benign incidental findings of osteopoikilosis on Tc-99m MDP bone SPECT/CT: a case report and literature review
Tsai SY, Wang SY, Shiau YC, Wu YW • Medicine (Baltimore) (2016)
Key Findings:
- Multiple punctate sclerotic foci on radiograph showed no abnormal uptake on Tc-99m MDP bone scan with SPECT/CT
- The normal scan made bone metastasis unlikely and confirmed osteopoikilosis
- Symptoms (in this patient, hip pain) settled with conservative measures, underscoring the benign nature
- SPECT/CT can establish the diagnosis in a single step by combining the cold foci with their CT density
Clinical Implication: Provides the practical exam answer: when osteopoikilosis cannot be confidently distinguished from blastic metastases, a normal bone scan effectively excludes active disease and prevents unnecessary intervention.
Atypical enostoses - series of ten cases and literature review
Bedard T, Mohammed M, Serinelli S, Damron TA • Medicina (Kaunas) (2020)
Key Findings:
- Typical bone islands are painless, show a rose-thorn radiating margin, mean CT attenuation above 885 Hounsfield units, and no uptake on bone scan
- Atypical enostoses (pain, enlargement, increased uptake, aberrant attenuation) can mimic osteoblastic metastasis, low-grade central osteosarcoma, osteoid osteoma and osteoblastoma
- Some cases occurred in the setting of osteopoikilosis, and one in Gardner syndrome
- Atypical features should trigger further imaging and consideration of biopsy
Clinical Implication: Defines the threshold for concern: stable, dense, cold, painless foci are benign and need no action, whereas atypical features justify treating the lesion as potentially malignant and investigating accordingly.
Guidelines, Registries & Global Practice
A 'No-Guideline' Do-Not-Touch Lesion
Osteopoikilosis is too benign and too rare for any society (AAOS, BOA, EFORT, AO) to issue a dedicated guideline, and there is no disease registry. It instead appears in radiology and musculoskeletal-oncology teaching as one of the canonical do-not-touch lesions (alongside non-ossifying fibroma, fibrous cortical defect, bone island, and benign cortical irregularities). The globally consistent message is recognition, reassurance and avoidance of biopsy.
Global Epidemiology
- Prevalence: estimated around 1 in 50,000; Buschke-Ollendorff syndrome quoted near 1 in 20,000, with no geographic clustering
- Inheritance: autosomal dominant (germline LEMD3), reported worldwide across populations
- Detection: overwhelmingly incidental, on imaging performed for unrelated reasons
Reference Sources Instead of Guidelines
| Source | Type | Contribution |
|---|---|---|
| LEMD3 genetic studies (Hellemans 2004) | Molecular | Established autosomal-dominant LEMD3/MAN1 basis and the link to Buschke-Ollendorff and melorheostosis |
| Do-not-touch lesion radiology teaching | Educational consensus | Places osteopoikilosis among benign lesions that should not be biopsied |
| Atypical enostosis literature (Bedard 2020) | Case series | Defines imaging thresholds (CT attenuation, bone scan) that separate benign from suspicious foci |
Practice Variation by Resource Setting
| Setting | Diagnosis | Management |
|---|---|---|
| High-resource | Plain films, with CT attenuation and SPECT/CT or bone scan when metastases must be excluded; genetic testing available for syndromic cases | Recognition and reassurance; no treatment; document to prevent re-investigation |
| Limited-resource | Diagnosis on plain radiographs alone (symmetrical periarticular spotted pattern); advanced imaging and genetics often unavailable | Conservative reassurance; reserve referral for genuinely atypical or symptomatic foci |
Pragmatic Global Principles
- Diagnosis is usually radiographic; the symmetrical, periarticular, small-tubular-bone pattern is the key
- Use a bone scan (cold foci) as the simplest discriminator from blastic metastases when there is doubt
- Do not biopsy a typical lesion; reserve biopsy for atypical foci that could be malignant
- Examine the skin and ask about family history to identify Buschke-Ollendorff syndrome
- Document the diagnosis clearly so the patient is not repeatedly investigated for cancer
Viva Practice Scenarios
Use these scenarios to practise clinical reasoning and management decisions
CLINICAL SCENARIOChallenging
CLINICAL PROMPT
"A 45-year-old man has a chest and abdomen CT for abdominal pain. The report flags 'multiple sclerotic foci throughout the pelvis and proximal femora - query metastases'. He is otherwise well. How would you assess this?"
PRACTICAL APPROACH
My first priority is to determine whether these are benign enostoses (osteopoikilosis) or sclerotic metastases, because the implications are very different. I would take a focused history (any known malignancy, weight loss, bone pain, B symptoms) and examine him, including the skin for connective-tissue naevi suggesting Buschke-Ollendorff syndrome, and ask about family history given the autosomal-dominant inheritance. I would review the imaging carefully looking for the osteopoikilosis pattern: multiple small, round, well-defined, symmetrical foci clustered around joints in the epiphyses and metaphyses, sparing the axial flat bones, with very high CT attenuation (bone islands are typically well above 885 Hounsfield units). If the pattern is classic and he is asymptomatic, this is osteopoikilosis - a benign do-not-touch lesion. To exclude metastases when there is any doubt, I would arrange a Tc-99m bone scan: a normal scan with no increased uptake effectively excludes active metastases and confirms benignity. I would then reassure him, document the diagnosis prominently to prevent repeated work-up, and avoid biopsy. Importantly, I would not anchor - if he later develops genuine bone pain or a focus enlarges, I would reassess that lesion on its own merits.
KEY CLINICAL POINTS
Recognise the benign symmetrical periarticular spotted-bone pattern of osteopoikilosis
State that the key differential is osteoblastic metastases
Use a normal Tc-99m bone scan as the discriminator and avoid biopsy of a benign lesion
Examine the skin for Buschke-Ollendorff naevi and take a family history
COMMON PITFALLS
Assuming the spots are metastases and triggering a major oncological work-up
Biopsying a classic do-not-touch lesion
Forgetting to use the bone scan as the simple discriminating test
FURTHER QUESTIONS
"What is the underlying genetic cause of osteopoikilosis, and what is it called when it occurs with skin lesions?"
CLINICAL SCENARIOStandard
CLINICAL PROMPT
"You are shown a radiograph of both hands demonstrating numerous small round sclerotic foci in the carpals and phalanges. What is the diagnosis, and what is the underlying genetic basis?"
PRACTICAL APPROACH
This appearance - multiple small, round, well-defined sclerotic foci concentrated around the joints in the small tubular bones, distributed symmetrically - is characteristic of osteopoikilosis, the spotted-bone disease. Each focus is an enostosis, or bone island, made of mature compact lamellar bone. The genetic basis is a heterozygous germline loss-of-function mutation in LEMD3, which encodes the inner nuclear membrane protein MAN1. MAN1 normally antagonises TGF-beta and BMP signalling through receptor-activated SMADs, so losing this brake favours focal bone formation. It is inherited in an autosomal-dominant manner. When osteopoikilosis occurs together with cutaneous connective-tissue naevi it is called Buschke-Ollendorff syndrome, caused by the same gene. Osteopoikilosis also sits in a family with osteopathia striata and melorheostosis, which can overlap as mixed sclerosing bone dysplasia. Clinically it is benign and asymptomatic, so management is recognition and reassurance with no treatment.
KEY CLINICAL POINTS
Identify the spotted-bone pattern as osteopoikilosis
Know the LEMD3 (MAN1) germline mutation and TGF-beta / BMP antagonism
State the autosomal-dominant inheritance
Name Buschke-Ollendorff syndrome and the related sclerosing dysplasias
COMMON PITFALLS
Confusing it with melorheostosis (dripping candle wax) or osteopathia striata (linear striations)
Not knowing the gene (LEMD3 / MAN1)
Suggesting treatment for a benign asymptomatic condition
FURTHER QUESTIONS
"How would you confirm that one of these foci is benign rather than a metastasis or a low-grade osteosarcoma?"
CLINICAL SCENARIOCritical
CLINICAL PROMPT
"A patient with known prostate cancer is found to have multiple sclerotic bony foci. The oncologist asks whether these represent metastatic disease. How would you help resolve this?"
PRACTICAL APPROACH
In a patient with prostate cancer, sclerotic (osteoblastic) metastases are an important consideration, so I would not dismiss the finding, but I would also consider benign osteopoikilosis, which can coexist with cancer. I would compare the two patterns. Osteopoikilosis foci are small, round, uniform, well-defined, symmetrical and clustered around joints, sparing the axial flat bones, and are stable over time. Metastases are typically irregular, variable in size, often axial (spine, ribs, pelvis), may be symptomatic, and evolve. The decisive investigation is a Tc-99m bone scan: osteopoikilotic foci are metabolically inactive and show no increased uptake, whereas active metastases are hot. CT attenuation also helps, as bone islands have very high Hounsfield values. I would compare any prior imaging for stability. If the bone scan is normal and the pattern is classic, I would reassure the team that these are benign enostoses, not metastases, and recommend against biopsy. If, however, there is focal uptake, pain or an atypical focus, that specific lesion should be treated as suspicious and investigated, potentially with biopsy, because a real metastasis or even a low-grade osteosarcoma must not be missed.
KEY CLINICAL POINTS
Acknowledge that a cancer patient can have both benign osteopoikilosis and true metastases
Use pattern (small, round, symmetrical, periarticular, stable) plus bone scan to discriminate
Reassure and avoid biopsy when the scan is cold and the pattern is classic
Investigate any focus with uptake, pain or atypical features as potentially malignant
COMMON PITFALLS
Automatically labelling the foci as metastases because the patient has cancer
Failing to recognise that benign osteopoikilosis can coexist with malignancy
Ignoring an atypical or hot focus by anchoring on the benign diagnosis
FURTHER QUESTIONS
"What atypical features would make you treat one of these sclerotic foci as suspicious rather than benign?"
Osteopoikilosis
Clinical summary
Definition and Key Facts
Genetics
Radiographic Pattern
Confirming Benignity
Differential Diagnosis
Management
Exam Pearls
References
- Hellemans J, Preobrazhenska O, Willaert A, et al. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nature Genetics. 2004;36(11):1213-1218. PMID: 15489854.
- Wordsworth P, Chan M. Melorheostosis and osteopoikilosis: a review of clinical features and pathogenesis. Calcified Tissue International. 2019;104(5):530-543. PMID: 30989250.
- Tsai SY, Wang SY, Shiau YC, Wu YW. Benign incidental findings of osteopoikilosis on Tc-99m MDP bone SPECT/CT: a case report and literature review. Medicine (Baltimore). 2016;95(23):e3868. PMID: 27281099.
- Bedard T, Mohammed M, Serinelli S, Damron TA. Atypical enostoses - series of ten cases and literature review. Medicina (Kaunas). 2020;56(10):534. PMID: 33065973.
- Hassikou H, Tabache F, Safi S, Baaj M, Hadri L. Buschke-Ollendorff syndrome. Joint Bone Spine. 2008;75(2):212-214. PMID: 18313966.
- Frost M, Rahbek ET, Ejersted C, et al. Modeling-based bone formation transforms trabeculae to cortical bone in the sclerotic areas in Buschke-Ollendorff syndrome. Bone. 2020;135:115313. PMID: 32151766.
Evidence retrieved from PubMed. DOIs: 10.1038/ng1453; 10.1007/s00223-019-00543-y; 10.1097/MD.0000000000003868; 10.3390/medicina56100534; 10.1016/j.jbspin.2007.04.027; 10.1016/j.bone.2020.115313.